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Abstract
The present study was carried out to evaluate the physiological effects of seaweed supplementation on blood glucose levels, lipid profile, and
antioxidant enzyme activities in subjects with type 2 diabetes mellitus. Subjects were randomized into either a control group or a seaweed supplementation
group. Pills with equal parts of dry powdered sea tangle and sea mustard were provided to the seaweed supplementation group three times a day
for 4 weeks. Total daily consumption of seaweed was 48 g. We found that total dietary fiber intake was 2.5 times higher in subjects receiving
seaweed supplementation than in the control group. Accordingly, fasting blood glucose levels (p<0.01) and 2-hour postprandial blood glucose measurements 
(p<0.05) were decreased significantly in those ingesting seaweed. Furthermore, the serum concentrations of triglycerides were decreased and high-density
lipoprotein cholesterol was increased significantly in seaweed supplement group (p<0.05). However, the concentrations of total cholesterol and low-density
lipoprotein cholesterol were not affected by seaweed supplementation. The level of thiobarbituric acid reactive substances in erythrocytes was significantly
lower with seaweed supplementation compared to controls (p<0.05). Catalase and glutathione peroxidase activities with seaweed supplementation
were higher than the controls (p<0.05), but superoxide dismutase activity was not affected. We, therefore, conclude that ingestion of seaweed influences
glycemic control, lowers blood lipids, and increases antioxidant enzyme activities.
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Introduction2)
Type 2 diabetes is a hyperglycemic metabolic disease, a 
condition caused either by insufficient insulin secretion or insulin 
resistance (Berry et al., 2007; Sriplang et al., 2007). The number 
of diabetic patients is rapidly rising in most parts of the world. 
People with type 2 diabetes are often sedentary, obese, middle- 
aged adults with an increased risk of macrovascular disease, 
retinopathy, nephropathy, neuropathy, and hypertension (Berry 
et al., 2007; Goldberg, 1981). These health complications lead 
to increased morbidity and premature death (Hammoud et al., 
2000; Reven, 1987). Specific goals of medical nutrition therapy 
for diabetic patients include achieving and maintaining 
near-normal blood glucose levels, achieving optimal serum lipid 
levels, consuming adequate calories to achieve a reasonable body 
weight, and improving overall health by maintaining a balanced 
intake of macro- and micro-nutrients (American Diabetes 
Association, 2006; Hammoud et al., 2000). In general, 
maintaining blood glucose concentrations near normal ranges in 
these patients is accomplished with oral hypoglycemic/antihy-
perglycemic agents and insulin (American Diabetes Association, 
2006; Kilo, 1987; Saudek & Eder, 1979). However, these 
treatments have limited efficacy and are associated with 
undesirable side effects that have led to an increasing interest 
in the use of medicinal plants as an alternative management for 
type 2 diabetes (Betteridge, 1989). In fact, the American Diabetes 
Association (ADA) recommends a daily consumption of 20-35 
g of total fiber from sources that include both soluble and 
insoluble fiber (Ness & Powles, 1997; Steinmetz & Potter, 1996). 
Reports indicate that consuming diets rich in soluble and 
insoluble fiber induces satiety, improves glycemic control, and 
reduces total energy intake, adiposity, and blood lipids (Qureshia 
et al., 2001; Qureshia et al., 2002). 
Seaweeds are frequently consumed in Asia and occasionally 
consumed in the rest of the world. Edible seaweeds are rich in 
non-starch polysaccharides (dietary fiber), proteins, minerals, and 
vitamins (Jurkovic et al., 1995; Urbano & Goni, 2002). They 
have low lipid content and provide few calories. However, 
seaweed could interfere with the bioavailability of other dietary 
components (Lahaye, 1991; Wong et al., 1999). As seaweed 
polysaccharides cannot be entirely digested by human intestinal 
enzymes, they are considered to be a source of dietary fiber. 
Seaweed dietary fiber differs in composition, chemical structure, 
physico-chemical properties, and biological effects from the fiber 
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of land plants. Therefore, seaweed consumption could increase 
the variety of dietary fiber (Lahaye, 1991; Lahaye & Kaeffer, 
1997; Michel & MacFarlane, 1996).
There is great interest in the role of increased oxidative stress 
in the complications suffered by those with diabetes. Increased 
oxidative stress may result from an increase in free radical 
production. Seaweed is exposed to intense light and high oxygen 
concentrations, leading to the formation of free radicals and other 
strong oxidizing agents in it’s environment (Lahaye & Kaeffer, 
1997; Lahaye, 1991; Michel & MacFarlane, 1996; Wong et al., 
1999). The absence of oxidative damage in their structural 
components (polyunsaturated fatty acids) and the stability during 
storage suggest that their cells possess protective antioxidative 
systems (Lahaye, 1991; Wong et al., 1999). As of yet, only a 
few reports on the antioxidant activity of seaweeds have been 
published. Since seaweeds are rich in polysaccharides, minerals, 
proteins, and vitamins, a documented antioxidant activity would 
elevate their value in the human diet and as food and 
pharmaceutical supplements (Albu et al., 2004; Berge et al., 
2002; Burritt et al., 2002; Heo et al., 2005; Yuan & Walsh, 2006).
Subjects and Methods 
Subject selection
Nine men and eleven women with type 2 diabetes were selected 
according to the following specific criteria: diabetes controlled 
by diet and or oral hypoglycemic agents, body mass index 
(kg/m
2) < 35, fasting plasma glucose concentrations > 150 mg/dl 
(150-300 mg/dl), no consumption of lipid-lowering drugs, and 
being 40 to 70 years of age. Aside from diabetes, all subjects 
were in good general health and had no clinical or laboratory 
evidence of renal, hepatic, or cardiovascular disease. 
Experimental design
This study was approved by the Ethics Committee and the 
Institutional Review Board for Human Subjects Research at 
Hanyang University Hospital, Seoul, Korea. Subjects were 
randomized into either a control group or a seaweed supple-
mentation group. Pills with equal parts of dry powdered sea 
tangle and sea mustard were provided to the seaweed 
supplementation group three times a day for 4 weeks. Total daily 
consumption of seaweed was 48 g. The subjects continued normal 
daily activities and exercise patterns.
Dietary assessment
Food intake of each subject was quantitatively evaluated by 
24 hour recall. The dietitian collected data using graduated 
models to estimate the size of food portions. Daily nutrient intake 
was calculated using the Computer Aided Nutritional Analysis 
program (Can-Pro) software (version 3.0; The Korean Nutrition 
Society) based on data from Korean food-composition tables. 
Biochemical analysis
Blood samples were taken at study entry and at 4 weeks. We 
measured blood glucose, total cholesterol (T-C), high-density 
lipoprotein cholesterol (HDL-C), low-density lipoprotein choles-
terol (LDL-C), and triglycerides (TG), hemoglobin A1c (HbA1c) 
after fasting, and 2-hour postprandial blood glucose levels 
(PP-2hr BG). The following determinations were made on the 
same day, according to standard protocol at the biochemical 
laboratory of Hanyang University Hospital, a certified clinical 
laboratory using HITACHI 7600-110 Auto Biochemistry 
Analyzer (Hitachi Electronics, Japan). Glucose was measured 
using the glucose oxidase (GOD)-peroxidase (POD) enzymatic 
colorimetric test . T-C was determined using the enzymatic 
cholesterol oxidase (COD)-peroxidase (POD) colorimetric test. 
TG was based on enzymatic method using lipoprotein lipase, 
glycerol kinase, glycerol phosphate oxidase and peroxidase 
(Fossati & Prencipe et al, 1982). HDL-C was determined 
enzymatically with dextran sulfate–magnesium method (Warnick 
et al., 1982). LDL-C was measured enzymatically (Friedewald 
et al., 1972) and HbA1C was analyzed using high performance 
liquid chromatography (HPLC) method (Jeppsson et al., 1986). 
For erythrocyte lysates, blood was collected in tubes containing 
EDTA and then centrifuged at 1500 g for 10 minutes at 4°C. 
The supernatant containing the plasma and buffy coat was 
discarded. The red blood cell pellet was washed three times with 
cold saline and frozen immediately at -70°C until analysis. 
Hemoglobin was separated from the blood cells by precipitation 
with an ethanol/chloroform mixture, followed by continuous 
shaking for 5 min and centrifugation at 2500 g for 20 min. The 
supernatants were used to determine enzyme activity.
The total amount of lipid peroxidation products was assayed 
with the thiobarbituric acid method, which quantifies thio-
barbituric acid reactive substances (TBARS) at 532 nm. 
Superoxide dismutase (SOD, EC 1.15.1.1) activity was measured 
using pyrogallol (Marklund, 1984). Catalase (EC 1.11.1.6) 
activity was calculated by spectrophotometrically measuring the 
disappearance of H2O2 at 240 nm (Aebi, 1984, Claiborne, 1984). 
Glutathione peroxidase (GSH-Px, EC 1.4.1.9) activity was 
assayed according to the method of Flohe and Gunzler (1984)
The hemoglobin concentration of lysates was determined 
spectrophotometrically at 546 nm using the cyanmethaemoglobin 
method of Mahoney et al. (1993). All assays were carried out 
in triplicate using a spectrophotometer (Beckman-Coulter DU 
400, Fullerton, CA, USA).
Statistical analysis
For statistical analyses, the SPSS/PC computer program 
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Table 1. General characteristics of subject
Group
1) CG SG
Sex (M/F) 5/5 4/6
Age (year) 54.8 ± 2.5
2) 54.4 ± 3.1
Height (cm) 163.1 ± 3.2 162.8 ± 3.1
Weight (kg) 64.3 ± 3.2 63.8 ± 4.3
BMI (kg/m
2)
3) 24.2 ± 0.7 23.2 ± 1.1
BP (mmHg)
 4)
Systolic BP 125.0 ± 3.3 120.0 ± 2.2
Diastolic BP 80.0 ± 1.9 77.8 ± 2.2
1) C G  :  c o n t r o l  g r o u p ,  S G  :  s e a w e e d  g r o u p
2) Data  is  expressed  as  mean ± S.E.
3) BMI  :  Body  Mass  Index
4) B P  :  B l o o d  p r e s s u r e 
Table 2. Nutrients intake of control and seaweed group 
Group
1) CG SG
Carbohydrate (g) 376.7 ± 27.5
2) 371.8 ± 21.6 
Fat (g) 48.2 ± 8.5 49.6 ± 2.5
Protein (g) 92.0 ± 9.6 89.8 ± 4.4 
Fiber (g) 12.3 ± 0.7 30.1 ± 1.7***
3)
Calories (kcal) 2308.6 ± 128.2 2292.8 ± 64.3
CFP ratio
4) 65: 19: 16 65: 19: 16
1) C G  :  c o n t r o l  g r o u p ,  S G  :  s e a w e e d  g r o u p
2) Data  is  expressed  as  mean ± S.E.
3) ***  Significant  difference  between  groups  by  independent  t-test:  p<0.001 
4) CFP  ratio=  Carbohydrate  :  Fat  :  Protein
Table 3. Blood glucose levels before and after the supplementation period




2) 177.0 ± 14.2
3) 172.9 ± 13.6 NS
SG 181.7 ± 8.2 151.8 ± 8.7 p<0.01
PP-2hrBG (mg/㎗)
CG 266.7 ± 25.8 254.4 ± 22.8*
4) NS
SG 263.2 ± 13.0 203.1 ± 12.3 p<0.05
HbA1c (%)
CG   7.9 ± 0.3   7.1 ± 0.4 NS
SG   8.4 ± 0.3   7.7 ± 0.3 NS
1) Paired t-test was used to compare means by experimental period (baseline vs. 
4wk)  in  each  group.
2) C G  :  c o n t r o l  g r o u p ,  S G  :  s e a w e e d  g r o u p
3) Data  was  expressed  as  mean ± S.E.
4) *  Significant  difference  between  groups  by  independent  t-test:  p<0.05 
FBG: Fasting blood glucose level, PP-2hr, BG: Postprandial blood glucose level, 
HbA1c:  Glycosylated  hemoglobin  A1c  level 
Table 4. Blood lipids levels before and after the supplementation period 




2) 194.4 ± 11.0
3) 187.1 ± 8.3 NS
SG 191.6 ± 6.5 174.4 ± 12.9 NS
TG (mg/㎗)
CG 182.6 ± 24.0 178.3 ± 20.7 NS
SG 171.2 ± 36.7 111.8 ± 17.6*
4) p<0.05
LDL-C (mg/㎗)
CG 121.7 ± 12.4 123.4 ± 13.3 NS
SG 126.1 ± 10.0  95.0 ± 9.0* NS
HDL-C (mg/㎗)
CG  39.6 ± 2.0  42.0 ± 1.5 NS
SG  37.1 ± 3.2  44.6 ± 2.9 p<0.05
1) Paired t-test was used to compare means by experimental period (baseline vs. 
4wk)  in  each  group.
2) C G  :  c o n t r o l g r o u p ,  S G  :  s e a w e e d  g r o u p
3) Data  was  expressed  as  mean ± S.E.
4) *  Significant  difference  between  groups  (CG  vs.  SG)  by  independent  t-test: 
p < 0.05 
T-C: total-cholesterol, TG: triglyceride, LDL-C: low density lipoprotein- cholesterol, 
HDL-C:  high  density  lipoprotein-cholesterol. 
expressed as means ± S.E. The significance in differences 
between the two groups was assessed by independent t-tests. The 
paired t-test was used to compare means for experimental periods 
in each group.
Results
Table 1 shows the characteristics of the two groups at the 
beginning of the study. There were no significant differences 
between subjects in the two groups with respect to age, height, 
weight, BMI or blood pressure. The 10 subjects in the control 
group included 5 men and 5 women, aged 54.8 ± 2.5 yr, with 
BMI of 24.2 ± 0.7 kg/m
2, systolic BP of 125.0 ± 3.3 mmHg, and 
diastolic BP of 80.0 ± 1.9 mmHg. The 10 subjects in the seaweed 
supplementation group included 4 men and 6 women, aged 54.4
± 3.1 yr, with BMI of 23.2 ± 1.1 kg/m
2, systolic BP of 120.0
± 2.2 mmHg, and diastolic BP of 77.8 ± 2.2 mmHg. 
Nutrient intake of the two groups during the 4 weeks is 
presented in Table 2. Intake of the two groups was identical in 
regards to the proportion of carbohydrates, fat, and protein. 65% 
of the calories were derived from carbohydrate, 16% were from 
protein, and 19% were from fat. Throughout the 4 weeks, food 
intake did not differ appreciably between the two groups, except 
for fiber intake. As expected, the mean total dietary fiber intake 
in patients receiving seaweed supplementation was 30.1g/day, 
which was 2.5 times higher than the 12.3g/day in the control 
group (p<0.001).
The mean change in fasting blood glucose (FBG) levels, PP-2hr 
BG, and HbA1C are shown in Table 3. There were no significant 
differences in FBG, PP-2hr BG, and HbA1C  at baseline between 
the two groups. After seaweed supplementation, the concentra-
tions of FBG and PP-2hr BG were decreased significantly in 
patients receiving seaweed supplementation, but there were no 
significant differences in controls. PP-2hr BG concentration in 
controls was 254.4 ± 22.8 mg/㎗  and significantly higher as 
compared to 203.1 ± 12.3 mg/㎗ in the seaweed supplementation 
group (p<0.05). In other words, increased dietary fiber intake 
resulting from supplementation had beneficial effects on FBG 
and PP-2hr BG. Little change was observed in the level of HbA1C 
in both the supplemented and control groups after 4 weeks and 
these changes were not statistically significant.
The mean change in blood lipid concentrations is shown in Min Sun Kim Et Al. 65




TBARS (㎍/mg Hb) 25.1 ± 3.6
2) 16.9 ± 3.7*
3) 
SOD (Unit/mg Hb) 0.22 ± 0.03  0.20 ± 0.02
Catalase (Unit/mg Hb) 0.09 ± 0.02  0.67 ± 0.17*
GSH-Px (Unit/mg Hb) 0.03 ± 0.01 0.32 ± 0.1*
1) C G  :  c o n t r o l  g r o u p ,  S G  :  s e a w e e d  g r o u p
2) Data  was  expressed  as  mean ± S.E.
3) *  Significant  difference  between  groups  by  independent  t-test:  p < 0.05 
Table 4. There were no significant differences in T-C, TG, 
LDL-C and HDL-C concentration at baseline between the two 
groups. After seaweed supplementation, the concentration of TG 
was decreased and HDL-C was increased significantly (p<0.05). 
There were no significant differences in the control group for 
the same time period. Both groups had lower T-C level compared 
with baseline, but these differences were not significant. Seaweed 
supplemented group showed significantly lower TG and LDL-C 
levels compared with control group (p<0.05) after 4 weeks .
Our results on oxidants and antioxidants are presented in Table 
5. Seaweed supplementation significantly lowered the level of 
TBARS in erythrocytes as compared to controls (p<0.05). 
Seaweed supplementation also increased catalase and GSH-Px 
activities (p<0.05). However, SOD activity was not affected by 
seaweed supplementation. 
Discussion
We evaluated the effects of seaweed intake on blood glucose 
levels, lipid profile, and antioxidant enzyme activities in patients 
with type 2 diabetes. 
Seaweed was provided in the form of pills that were made 
with powdered sea tangle and sea mustard. Sea tangle and sea 
mustard are frequently consumed in Asia and occasionally in 
the rest of the world. Seaweeds are classified into three groups: 
brown algae, red algae, and green algae, and each of these groups 
differ with regard to their reserve and cell-wall polysaccharides 
(Jimenez-Escrig & Sanchez-Muniz, 2000). Sea tangle and sea 
mustard are the most commonly used seaweeds in Korea (Heo 
et al., 2005), and both belong to the family of brown algae. 
Dietary fiber from brown algae is essentially derived of four 
families of polysaccharides: laminarans, alginates, fucans, and 
cellulose (Jimenez-Escrig & Sanchez-Muniz, 2000; Renn, 1990). 
Sea tangle and sea mustard, which are rich in indigestible 
polysaccharides, appear to be good sources of soluble dietary 
fiber. The total dietary fiber content of seaweeds ranges between 
25-75% (on a dry weight basis), and 51-85% of which is 
water-soluble fiber (Renn, 1990). 
In this study, the total dietary fiber intake of subjects given 
seaweed was 30.1g/day, which was 2.5 times higher than the 
12.3 g/day of controls. Consistent with the increase in dietary 
fiber, the concentrations of FBG and PP-2hr BG were decreased 
significantly relative to baseline, which may result from a delay 
in glucose absorption by fiber in seaweed. The decreased FBG 
levels after seaweed supplementation agreed with the results of 
Simpson  et al. (1979, 1981). In their studies, however, it was 
not clear whether the effects were due to the high-fiber diet, 
restricting the intake of fat, or both (Simpson et al., 1979). In 
a second study, the difference in daily fiber intake was extremely 
high and was achieved mainly by a leguminous diet (Simpson 
et al., 1981). In this study, the individual energy intake was kept 
constant and the ratio of protein, fat, and carbohydrates was 
maintained to isolate the effect of fiber. 
Diabetic and insulin resistant individuals tend to have an 
atherogenic blood lipid profile with increased serum triglyceride, 
low HDL-cholesterol, and small, dense LDL-particles (Saudek 
& Eder, 1979; Kilo, 1987). Seaweed supplementation resulted 
in lower levels of TG and higher levels of HDL-C. Small changes 
were observed in the levels of T-C and LDL-C, however, these 
changes were not statistically significant. The results agree with 
earlier studies that reported decreased lipid levels with diets 
containing gel-forming fiber (Jurkovic et al., 1995; Qureshia et 
al., 2001, 2002; Unbano & Goni, 2002; Wursch & Pi-Sunyer, 
1997)
The mechanism by which fiber lowers blood cholesterol 
remains undefined. Evidence suggests that some soluble fibers 
bind bile acids or cholesterol during the intraluminal formation 
of micelles (Schroder, 2007; Shafrir, 1996). The resulting 
reduction in the cholesterol content of liver cells leads to an 
up-regulation of the LDL receptors and thus to an increased 
clearance of LDL cholesterol. Other suggested mechanisms 
include inhibition of hepatic fatty acids synthesis by products 
of fermentation (production of short-chain fatty acids such as 
acetate, butyrate, propionate); changes in intestinal motility; 
fibers with high viscosity causing decreased absorption of 
macronutrients, leading to increased insulin sensitivity; and 
increased satiety, leading to lower overall energy intake 
(Schroder, 2007). 
Seaweeds are exposed to a combination of light and high 
oxygen concentrations, which lead to the formation of free 
radicals and other strong oxidizing agents. However, they seldom 
suffer from serious photodynamic damage during metabolism. 
This fact implies that their cells have protective antioxidative 
mechanisms and compounds (Yuan & Walsh, 2006). Seaweeds 
are rich source of antioxidants. Recently, potential antioxidants 
have been identified as pigments (e.g. fucoxanthin, astaxanthin, 
carotenoid) and polyphenols (e.g. phenolic acid, flavonoid, 
tannins). These compounds are widely distributed in seaweeds 
and known to exhibit high antioxidative activities (Yuan et al., 
2005a). These antioxidants act by scavenging reactive oxygen 
species and inhibiting lipid peroxidation (Yuan et al., 2005b). 
TBARS are the most commonly used markers for oxidation. 
In this study, TBARS levels in erythrocytes of those given 
seaweed supplementation were significantly lower than in 
controls. Catalase and GSH-Px activities in the seaweed 66 Seaweed Supplementation And Type 2 Diabetes Mellitus
supplementation group were higher than in controls. However, 
SOD activity was not affected by seaweed supplementation. 
These results suggest that seaweed supplementation decreases 
oxidative stress in vivo due to a combination of improved 
antioxidant activities and decreased peroxidation processes.
We conclude that addition of seaweed influences glycemic 
control and may be effective in lowering blood lipids and 
improving antioxidant enzyme activities. Accordingly, such 
effects may reduce risk factors for cardiovascular disease in 
patients with type 2 diabetes. However, to confirm these effects 
and to make dietary recommendations for patients with type 2 
diabetes, further studies are necessary.
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